UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation -metaplasia -adenocarcinoma sequence

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4975-4982

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 782: Circulating tumour DNA-based molecular response predicts treatment outcome in multiple myeloma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.782-782

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3806: Investigating the role of miRNA-34a in the resistance of esophageal adenocarcinoma to neoadjuvant chemoradiation therapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3806-3806

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5087: Thromboxane synthase and thromboxane receptor targeting have anti-angiogenic efficacy in-vivo and reduce angiogenic secretions from human colorectal tumor explants ex-vivo

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5087-5087

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1592: Mitochondrial dysfunction and radioresistance in esophageal cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1592-1592

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3373: Circulating tumour DNA mutations correlate with relapse in a phase II trial of bortezomib-primary refractory multiple myeloma patients receiving salvage therapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3373-3373

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4124: Pre-treatment complement system serum protein levels predict pathological response to neoadjuvant chemoradiotherapy for esophageal cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4124-4124

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1104: Insulin-like growth factor-1 is elevated in viscerally obese oesophageal adenocarcinoma patients and expression of its receptor correlates with tumor invasiveness

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1104-1104

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 791: T cells in visceral adipose tissue: A potential source of inflammation to drive tumorigenesis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.791-791

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1556: Adipose tissue upregulates MMP9 expression in oesophageal cancer promoting invasion and migration in vitro and correlates with obesity status and poor differentiation in vivo

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1556-1556

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1103: Expression profile and role of thromboxane synthase in NSCLC: Correlation with tumor angiogenesis and patient survival

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1103-1103

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3991: miR-31 modulates tumor sensitivity to radiation in esophageal cancer by regulation of DNA repair genes

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3991-3991

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5185: Omental adipose tissue increases the proliferative, migratory and invasive capacity of esophageal adenocarcinoma via up regulation of focal adhesion and endothelial mesenchymal transition pathways

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5185-5185

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2283: The role of insulin-like growth factor-1 and insulin like growth factor-1 receptor in obesity and oesophageal cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2283-2283

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-291: Central obesity drives oesophageal tumor cell growth through VEGF-mediated mechanisms

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-291-LB-291

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5562: Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5562-5562

2012

Link zum Volltext

Verfügbarkeit prüfen

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2017-12, Vol.77 (24), p.6999-7013

2017

Link zum Volltext

Verfügbarkeit prüfen

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (12), p.2663-2675

2020

Link zum Volltext

Verfügbarkeit prüfen

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4), p.787-795

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis

Cancer research (Chicago, Ill.), 2016-10, Vol.76 (19), p.5798-5809

2016

Link zum Volltext

Verfügbarkeit prüfen

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1536-1544

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4143-4149

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 225: Assessing and enriching human tumor cell content in patient-derived cancer xenografts and co-cultures

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.225-225

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3126: H3B6527, a selective and potent FGFR4 inhibitor for FGF19-driven hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3126-3126

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3969: Pediatric preclinical testing program (PPTP) evaluation of BMN 673, an inhibitor of poly-adp ribose polymerase (PARP), with temozolomide (TMZ)

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3969-3969

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(12)
Oncology
(12)
Science & Technology
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Female
(6)
Animals
(5)
Cell Line, Tumor
(5)
Male
(5)
Antineoplastic Agents
(4)
Middle Aged
(4)
Neuroblastoma - Pathology
(4)
Neurology
(4)
Pharmacology. Drug Treatments
(4)
Tumors
(4)
Tumors Of The Nervous System. Phacomatoses
(4)
Aged
(3)
Antibodies, Monoclonal
(3)
Cell Line
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Cancer Res
(1)

Menü

Weitere Dienste

Einstellungen

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation -metaplasia -adenocarcinoma sequence

Abstract 782: Circulating tumour DNA-based molecular response predicts treatment outcome in multiple myeloma

Abstract 3806: Investigating the role of miRNA-34a in the resistance of esophageal adenocarcinoma to neoadjuvant chemoradiation therapy

Abstract 5087: Thromboxane synthase and thromboxane receptor targeting have anti-angiogenic efficacy in-vivo and reduce angiogenic secretions from human colorectal tumor explants ex-vivo

Abstract 1592: Mitochondrial dysfunction and radioresistance in esophageal cancer

Abstract 3373: Circulating tumour DNA mutations correlate with relapse in a phase II trial of bortezomib-primary refractory multiple myeloma patients receiving salvage therapy

Abstract 4124: Pre-treatment complement system serum protein levels predict pathological response to neoadjuvant chemoradiotherapy for esophageal cancer

Abstract 1104: Insulin-like growth factor-1 is elevated in viscerally obese oesophageal adenocarcinoma patients and expression of its receptor correlates with tumor invasiveness

Abstract 791: T cells in visceral adipose tissue: A potential source of inflammation to drive tumorigenesis

Abstract 1556: Adipose tissue upregulates MMP9 expression in oesophageal cancer promoting invasion and migration in vitro and correlates with obesity status and poor differentiation in vivo

Abstract 1103: Expression profile and role of thromboxane synthase in NSCLC: Correlation with tumor angiogenesis and patient survival

Abstract 3991: miR-31 modulates tumor sensitivity to radiation in esophageal cancer by regulation of DNA repair genes

Abstract 5185: Omental adipose tissue increases the proliferative, migratory and invasive capacity of esophageal adenocarcinoma via up regulation of focal adhesion and endothelial mesenchymal transition pathways

Abstract 2283: The role of insulin-like growth factor-1 and insulin like growth factor-1 receptor in obesity and oesophageal cancer

Abstract LB-291: Central obesity drives oesophageal tumor cell growth through VEGF-mediated mechanisms

Abstract 5562: Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models

Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis

Abstract 225: Assessing and enriching human tumor cell content in patient-derived cancer xenografts and co-cultures

Abstract 3126: H3B6527, a selective and potent FGFR4 inhibitor for FGF19-driven hepatocellular carcinoma

Abstract 3969: Pediatric preclinical testing program (PPTP) evaluation of BMN 673, an inhibitor of poly-adp ribose polymerase (PARP), with temozolomide (TMZ)

Aktive Filter

Suchergebnisse filtern